Conference abstract · 23 Jun 2025
Conference abstractPublished 5 Sep 2011
Small molecule activation of APOBEC3G host defense
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
APOBEC3G (A3G) is a protein expressed in human cells that serves as an antiviral hostdefense factor. While the majority of studies have suggested that A3G DNA mutagenic activity on nascent single stranded proviral DNA inhibits viral replication, recent studies suggested that circumstances might exist in permissive cells where A3G mutagenic activity may benefi t the virus and promote the emergence of drug-resistant strains. We have identifi ed small molecules for therapeutic development that are also novel research tools for addressing the urgent question of whether endogenously expressed A3G deaminase activity can be modulated to exceed a mutagenic threshold necessary for it to have antiviral activity. Th is is a relevant question because, in permissive cells, A3G is almost entirely ?switched off ? through its interaction with cellular RNA and this low level of activity may benefi t the virus. Compounds have been identifi ed that activate A3G deaminase activity by dissociating RNA from the enzyme and these compounds had a dose-dependent antiviral eff ect in permissive cells where A3G was sequestered as high molecular mass complexes. Th ese compounds are fi rst in their class and show that RNA inhibition of A3G is reversible in living cells. Th ese compounds also hold the potential to preemptively inhibit HIV post-entry by making cellular A3G more eff ective as antiviral without the need for A3G to become encapsidated. As such A3G activators may have utility in disease prevention.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Antivirals & Antiretrovirals.
Conference abstract · 23 Jun 2025
Exploring signature proteins to design a novel multi-epitope vaccine candidate against Mycobacterium tuberculosis: An in-silico approach
Conference abstract · 23 Jun 2025
Correlation Between the Rh/ABO system and infection due to sars cov2 in morocco
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Antivirals & Antiretrovirals
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Harold C. Smith”
